IBDEI0FU ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7628,2)
 ;;=^268777
 ;;^UTILITY(U,$J,358.3,7629,0)
 ;;=365.00^^49^559^33
 ;;^UTILITY(U,$J,358.3,7629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7629,1,3,0)
 ;;=3^Glaucoma,Suspects
 ;;^UTILITY(U,$J,358.3,7629,1,4,0)
 ;;=4^365.00
 ;;^UTILITY(U,$J,358.3,7629,2)
 ;;=^97584
 ;;^UTILITY(U,$J,358.3,7630,0)
 ;;=365.60^^49^559^10
 ;;^UTILITY(U,$J,358.3,7630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7630,1,3,0)
 ;;=3^Glauc w/ Unspec Ocular D/O
 ;;^UTILITY(U,$J,358.3,7630,1,4,0)
 ;;=4^365.60
 ;;^UTILITY(U,$J,358.3,7630,2)
 ;;=^268775
 ;;^UTILITY(U,$J,358.3,7631,0)
 ;;=365.9^^49^559^35
 ;;^UTILITY(U,$J,358.3,7631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7631,1,3,0)
 ;;=3^Glaucoma,Unspec
 ;;^UTILITY(U,$J,358.3,7631,1,4,0)
 ;;=4^365.9
 ;;^UTILITY(U,$J,358.3,7631,2)
 ;;=^51160
 ;;^UTILITY(U,$J,358.3,7632,0)
 ;;=365.22^^49^559^12
 ;;^UTILITY(U,$J,358.3,7632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7632,1,3,0)
 ;;=3^Glaucoma,Acute Angle Closure
 ;;^UTILITY(U,$J,358.3,7632,1,4,0)
 ;;=4^365.22
 ;;^UTILITY(U,$J,358.3,7632,2)
 ;;=^268754
 ;;^UTILITY(U,$J,358.3,7633,0)
 ;;=365.59^^49^559^7
 ;;^UTILITY(U,$J,358.3,7633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7633,1,3,0)
 ;;=3^Glauc Assoc w/ Lens D/O
 ;;^UTILITY(U,$J,358.3,7633,1,4,0)
 ;;=4^365.59
 ;;^UTILITY(U,$J,358.3,7633,2)
 ;;=^268773
 ;;^UTILITY(U,$J,358.3,7634,0)
 ;;=365.44^^49^559^9
 ;;^UTILITY(U,$J,358.3,7634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7634,1,3,0)
 ;;=3^Glauc Assoc w/ Systemic Syndromes
 ;;^UTILITY(U,$J,358.3,7634,1,4,0)
 ;;=4^365.44
 ;;^UTILITY(U,$J,358.3,7634,2)
 ;;=^268769
 ;;^UTILITY(U,$J,358.3,7635,0)
 ;;=377.14^^49^559^36
 ;;^UTILITY(U,$J,358.3,7635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7635,1,3,0)
 ;;=3^Glaucomatous Atrophy
 ;;^UTILITY(U,$J,358.3,7635,1,4,0)
 ;;=4^377.14
 ;;^UTILITY(U,$J,358.3,7635,2)
 ;;=^269218
 ;;^UTILITY(U,$J,358.3,7636,0)
 ;;=365.14^^49^559^15
 ;;^UTILITY(U,$J,358.3,7636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7636,1,3,0)
 ;;=3^Glaucoma,Infantile/Juv
 ;;^UTILITY(U,$J,358.3,7636,1,4,0)
 ;;=4^365.14
 ;;^UTILITY(U,$J,358.3,7636,2)
 ;;=^268750
 ;;^UTILITY(U,$J,358.3,7637,0)
 ;;=743.20^^49^559^3
 ;;^UTILITY(U,$J,358.3,7637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7637,1,3,0)
 ;;=3^Buphthalmous,Unsp w/ Oth Ocu Abnormal
 ;;^UTILITY(U,$J,358.3,7637,1,4,0)
 ;;=4^743.20
 ;;^UTILITY(U,$J,358.3,7637,2)
 ;;=^59682
 ;;^UTILITY(U,$J,358.3,7638,0)
 ;;=378.83^^49^560^3
 ;;^UTILITY(U,$J,358.3,7638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7638,1,3,0)
 ;;=3^Convergence Insufficiency
 ;;^UTILITY(U,$J,358.3,7638,1,4,0)
 ;;=4^378.83
 ;;^UTILITY(U,$J,358.3,7638,2)
 ;;=Convergence Insufficiency^269277
 ;;^UTILITY(U,$J,358.3,7639,0)
 ;;=378.00^^49^560^5
 ;;^UTILITY(U,$J,358.3,7639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7639,1,3,0)
 ;;=3^Esotropia
 ;;^UTILITY(U,$J,358.3,7639,1,4,0)
 ;;=4^378.00
 ;;^UTILITY(U,$J,358.3,7639,2)
 ;;=Esotropia^42597
 ;;^UTILITY(U,$J,358.3,7640,0)
 ;;=378.10^^49^560^9
 ;;^UTILITY(U,$J,358.3,7640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7640,1,3,0)
 ;;=3^Exotropia
 ;;^UTILITY(U,$J,358.3,7640,1,4,0)
 ;;=4^378.10
 ;;^UTILITY(U,$J,358.3,7640,2)
 ;;=Exotropia^43741
 ;;^UTILITY(U,$J,358.3,7641,0)
 ;;=378.41^^49^560^4
 ;;^UTILITY(U,$J,358.3,7641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7641,1,3,0)
 ;;=3^Esophoria
 ;;^UTILITY(U,$J,358.3,7641,1,4,0)
 ;;=4^378.41
 ;;^UTILITY(U,$J,358.3,7641,2)
 ;;=Esophoria^265435
 ;;^UTILITY(U,$J,358.3,7642,0)
 ;;=378.42^^49^560^8
 ;;^UTILITY(U,$J,358.3,7642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7642,1,3,0)
 ;;=3^Exophoria
